These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4511739)

  • 1. Monoamine oxidase activity of rat spinal cord after transection.
    Goridis C; Meek JL; Neff NH
    Life Sci I; 1972 Sep; 11(18):861-6. PubMed ID: 4511739
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a specific monoamine oxidase associated with sympathetic nerves.
    Goridis C; Neff NH
    Neuropharmacology; 1971 Sep; 10(5):557-64. PubMed ID: 5126693
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of monoamine oxidases in sympathetic nerve and pineal gland.
    Yang HY; Goridis C; Neff NH
    J Neurochem; 1972 May; 19(5):1241-50. PubMed ID: 5025123
    [No Abstract]   [Full Text] [Related]  

  • 4. A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.
    Houslay MD; Tipton KF
    Biochem J; 1974 Jun; 139(3):645-52. PubMed ID: 4850215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). II. Comparison of M & B 9302 inhibition with that of iproniazid.
    Hall DW; Logan BW
    Biochem Pharmacol; 1969 Aug; 18(8):1955-9. PubMed ID: 5811628
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 8. Some observations upon a new inhibitor of monoamine oxidase in brain tissue.
    Johnston JP
    Biochem Pharmacol; 1968 Jul; 17(7):1285-97. PubMed ID: 5659776
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

  • 11. The inhibition of rat liver mitochondrial monoamine oxidase by 2-bromo-2-phenylacetaldehyde.
    Tipton KF
    Biochem Pharmacol; 1969 Oct; 18(10):2559-61. PubMed ID: 5403991
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine oxidase in rat arteries: evidence for different forms and selective localization.
    Coquil JF; Goridis C; Mack G; Neff NH
    Br J Pharmacol; 1973 Aug; 48(4):590-9. PubMed ID: 4788203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.
    Lader MH; Sakalis G; Tansella M
    Psychopharmacologia; 1970 Aug; 18(1):118-23. PubMed ID: 4943186
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].
    Palm D; Magnus U; Grobecker H; Jonsson J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):281-300. PubMed ID: 4233003
    [No Abstract]   [Full Text] [Related]  

  • 16. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase. II. Time-dependent inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1974 Feb; 23(3):629-36. PubMed ID: 4822747
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type.
    Goridis C; Neff NH
    Br J Pharmacol; 1971 Dec; 43(4):814-8. PubMed ID: 4339887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the dual nature of monoamine oxidase.
    Knoll J
    Horiz Biochem Biophys; 1978; 5():37-64. PubMed ID: 355087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.